期刊文献+

2型糖尿病外周动脉疾病患者血浆adipsin的水平变化 被引量:2

Changes of Plasma Adipsin Levels in Type 2 Diabetes Millitus with Peripheral Artery Disease Patients
在线阅读 下载PDF
导出
摘要 目的了解adipsin在2型糖尿病患者及2型糖尿病外周动脉疾病患者血浆中的水平,探讨adipsin对2型糖尿病及外周动脉疾病发生发展的作用。方法选择2型糖尿病患者50名、2型糖尿病外周动脉疾病患者50名、正常对照者50名。检测血浆adipsin水平,同时测量踝臂指数,检测血压、血糖、血清胰岛素、血脂及计算体质指数、胰岛素抵抗指数等。结果 2型糖尿病外周动脉疾病组血浆adipsin水平较2型糖尿病组及正常对照组升高,2型糖尿病组血浆adipsin水平较正常对照组升高。adipsin水平与踝臂指数呈负相关。结论 adipsin水平的升高可能参与2型糖尿病外周动脉疾病的发生发展。 Aim To understand the level of plasma adipsin in type 2 diabetes millitus and type 2 diabetes millitus with peripheral arterial disease patients and to discuss the effect of adipsin in the occurrence and development of type 2 diabetes millitus and peripheral arterial disease.Methods 50 cases of type 2 diabetes millitus,50 cases of type 2 diabetes with peripheral arterial disease and 50 cases of normal controls were selected.Detected plasma serum and measured the ankle-brachial index.Detected blood pressure,blood glucose,serum insulin and blood fat.Calculated body mass index and insulin resistant index et al.Results The level of plasma adipsin in type 2 diabetes millitus with peripheral arterial disease group was higher than that of type 2 diabetes millitus group and normal control group.The level of plasma adipsin in type 2 diabetes millitus group was higher than that of normal control group.There was negative correlation between adipsin and ankle-brachial index.Conclusions The increase of circulating adipsin may be involved in the me tabolism of type 2 diabetes mellitus and peripheral arterial disease.
出处 《中国动脉硬化杂志》 CAS CSCD 北大核心 2012年第3期257-260,共4页 Chinese Journal of Arteriosclerosis
基金 沈阳市卫生局科研课题项目(200809)
关键词 2型糖尿病 外周动脉疾病 adipsin Type 2 Diabetes Millitus Peripheral Arterial Disease Adipsin
作者简介 王晓蕾,硕士研究生,副主任医师,副教授,研究方向为糖尿病及其并发症的发病机制及治疗、血脂代谢,E-mail为syxiaolei@yahoo.com.cn。 时艺珊,硕士,主任医师,研究方向为糖尿病及其并发症的发病机制及治疗、甲状腺疾病诊治。 柏松,硕士,主任医师,研究方向为糖尿病的发病机制及治疗。
  • 相关文献

参考文献13

  • 1Criqui MH,Langer RD,Fronek A,et al.Mortality over aperiod of 10 years in patients with peripheral arterial dis-ease[J].N Engl J,1992,326:381-386.
  • 2Fowkes FG,Housley E,Cawood EH,et al.Edinburgh ar-tery study:prevalence of asymptomatic and symptomaticperipheral arterial disease in the general population[J].IntJ Epidemiol,1991,20:384-392.
  • 3Hirsch AT,Criqui MH,Treat-Jacobson D,et al.Peripher-al arterial disease detection,awareness,and treatment inprimary care[J].JAMA,2001,286:1 317-324.
  • 4Fukuhara A,Otsuki M,Shimomura I.Adiponectin,lep-tin,adipsin[J].Nihon Rinsho,2011,69(Suppl 1):221-224.
  • 5Zadeh-Vakili A,Ramezani Tehrani F,Hosseinpanah F.Waist circumference and insulin resistance:a communitybased cross sectional study on reproductive aged Iranianwomen[J].Diabetol Metab Syndr,2011,3(1):18.
  • 6Tsai AW,Folsom AR,Rosamond WD,et al.Ankle-bra-chial index and 7-year ischemic stroke incidence:the ARICstudy[J].Stroke,2001,32:1 721-724.
  • 7赵季红,孙婧,杨宁,石蕊,姜铁民,李玉明.踝臂指数评价2型糖尿病合并下肢外周动脉病患者疗效中的临床价值[J].中国动脉硬化杂志,2009,17(9):771-773. 被引量:4
  • 8Pascual M,Catana E,White T.Inhibition of complementalternative pathway in mice with Fab antibody to recombi-nant adipsin/factor D[J].Eur J Immunol,1993,23(6):1 389-392.
  • 9Cianflone K,Maslowska M,Sniderman AD.Acylationstimulating protein(ASP),an adipocyte autocrine:newdirections[J].Semin Cell Dev Biol,1999,10:31.
  • 10Fowkes FG,Housley E,Cawood EH,et al.EdinburghArtery Study:prevalence of asymptomatic and symptomat-ic peripheral arterial disease in the general population[J].Int J Epidemiol,1991,20:384-392.

二级参考文献12

  • 1王领军,胡大一,李田昌,余金明,布艾加尔,仝其广,魏毅东,吴琛.踝臂指数评价缺血性卒中患者下肢外周动脉病多中心临床研究[J].中国医药导刊,2005,7(1):27-29. 被引量:48
  • 2范利,杜瑞雪,李小鹰,韦立新.老年下肢动脉粥样硬化在糖尿病患者中的病理特点[J].中国动脉硬化杂志,2005,13(2):192-194. 被引量:6
  • 3Norgren L, Hiatt WR, Dormandy JA, et al. Inter-society consensus for the management of peripheral arterial disease ( TASC II) [ J ]. Eur J Vasc Endovasc Surg, 2007, 33 ( Suppll ) : S1-S75.
  • 4Paul M, Rachel P, Kristi R. Relationship between HbAlc level and peripheral arterial disease [J]. Diabetes Care, 2005, 28 (7) : 1 981-987.
  • 5Heather L, Gomlk J, Joshua A. Peripheral medal disease (PAD) [J]. Circulation, 2005, 111 (5) : e169-e172.
  • 6Greenland P, Abrams J, Aurigemma GP, et al. Prevention conference V : beyond secondary prevention: identifying the high-risk patient for primary prevention: noninvasive tests of atherosclerotie burden: writing group III [J]. circulation, 2000, 101: 16-22.
  • 7Ouriel K, Mcdonnell AE, Metz CE, et al. Critical evaluation of stress testing in the diagnosis of peripheral vascular disease [ J ]. Surgery, 1982, 91 : 6 86-693 :.
  • 8杨金刚,王建旗,李觉,等.外周动脉疾病诊疗指南[M].上海:同济大学出版社,2006.
  • 9Hankey GJ, Norman PE, Eikelboom JW. Medical treatment of peripheral arterial disease [J]. JAMA, 2006, 295 (5) : 547-553.
  • 10Hirsch AT, Haskal ZJ, Hertzer NR, et al. ACC/AHA 2005 guidelines for the management of patients with peripheral arterial disease [ J ]. J Am Coll Cardiol, 2006, 47 (6) : 1 239-312.

共引文献3

同被引文献7

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部